Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Adobe

- PMLiVE

CHMP recommends Teva’s generic version of Astellas’ Advagraf

Committee backs the drug for transplant rejection prophylaxis

- PMLiVE

NICE backs Pfizer’s Xeljanz for RA

But UK’s cost-effectiveness watchdog removes two drugs from CDF

Lilly strengthens team with in-house promotions

And two senior leaders retire

- PMLiVE

A New Managing Director Appointed for Lighthouse Medical Communications US

Lucid Group boost their US operations with the appointment of Andy Willmer as Managing Director for Lighthouse Medical Communications

Lucid Group Communications Limited

- PMLiVE

Ferring appoints executive VP and chief medical officer

Professor Klaus Dugi joins the pharma group from Boehringer Ingelheim

- PMLiVE

BMS appoints Saurabh Saha as senior VP, global head of translational medicine

He joins the R&D team from Atlas Venture

- PMLiVE

Pfizer could raise ‘up to $15bn’ from consumer unit sale

Would follow in the footsteps of Novartis, Boehringer and Merck & Co if it does strike a deal

Novacyt strengthens group with senior hire

Paul Eros joins as commercial director

Atlas Genetics appoints Jeffery Luber as CEO

Former CEO Dr John Clarkson will move into an executive chairman position

Gyroscope Therapeutics appoints CEO

Dr Soraya Bekkali joins from biotech firm Lysogene

- PMLiVE

Amra appoints new VP of North American sales Jeremy Edwards

Klas Themner and Simon Hager also join its Sweden base

- PMLiVE

BioStrata strengthens team with two new hires

James Reeve and Kat Steer join the marketing agency

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links